Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cambrex has received Good Manufacturing Practice (GMP) approval for its manufacturing site in Hyderabad, India, from the Danish Medicines Agency (DKMA) following its audit conducted in October 2010.
Subscribe to our email newsletter
Cambrex is a provider of products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.
The company also offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals.
With the DKMA certification Cambrex said that it will now accelerate the European launch of Nicotine Replacement Therapy (NRT) products (chewing gums, lozenges and mini-lozenges).
Cambrex Zenara president Ashok Narasimhan said they are very pleased with the results of the DKMA inspection.